Larry Einbinder
Neurology · Rockville, MDNPI 1609848936
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Novartis at 33.3% of the total. Reporting peaked in 2021 at $836 and has fallen 98.1% since, to $16 in 2025.
Across 123 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$651
- AbbVie$360
- Biohaven Pharmaceuticals, Inc.$130
- Upsher-smith Laboratories LLC$106
- Sunovion Pharmaceuticals Inc.$88
- Lundbeck LLC$82
- plus $539 from 21 others
What the payments were for
- Speaking & faculty fees$251%
- Food & beverage$1,93399%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 38 | $651 |
| AbbVie(2 entities) | 25 | $360 |
| Biohaven Pharmaceuticals, Inc. | 14 | $130 |
| Upsher-smith Laboratories LLC | 6 | $106 |
| Sunovion Pharmaceuticals Inc. | 5 | $88 |
| Lundbeck LLC | 5 | $82 |
| UCB, Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| GE HealthCare | 2 | $42 |
| Sanofi | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| EMD Serono, Inc. | 2 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $28 |
| Acorda Therapeutics, Inc | 1 | $25 |
| Amgen | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Pfizer | 1 | $20 |
| Grifols USA, LLC | 1 | $20 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| CSL Behring | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
| Adamas Pharmaceuticals, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
How this compares
$1,957 in reported general payments places this provider in the 55th percentile of 442 neurology providers in Maryland.
Other neurology in Rockville
- Chang Ching LinRockville$21K
- Daniel BeckerLutherville$1.6M
- Sangjin OhGlen Burnie$1.5M
- Pavel KleinBethesda$709K
- Ruwani GunawardaneFulton$479K
- Michael PolydefkisBaltimore$371K
- David CornblathLutherville$345K
- Shiv SaidhaBaltimore$298K
- Santiago Mazuera MesiaBaltimore$258K
- Bruce RabinLutherville$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.